Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Interserve-led consortium left as final bidder for cancer contract

A consortium led by Interserve Investments is the only remaining bidder for the £687 million contract to provide cancer services in Staffordshire.

Interserve Investments’ consortium also includes The Royal Wolverhampton Hospitals NHS Trust and the University Hospitals of North Midlands NHS Trust.

The two trusts were originally each separate bidders and among the five parties who made it through the pre-qualification stage for the contract before teaming up with Interserve Investments.

CSC Computer Sciences and United Health UK were the other two organisations to pre-qualify. Both, however, pulled out of the process.

In a statement to HSJ, the clinical commissioning groups tendering the contract said: "During the competitive dialogue with bidders on the programme, a number of individual organisations and providers came together and formed a bidding consortium.

"This brings together the public and private sector, including two local NHS trusts.

"It will bring together a wide range of skills and expertise to implement this innovative approach to the commissioning of cancer care.

"The consortium is the last remaining bidder."

The consortium has to submit a formal proposal over the next few months before the contract is awarded in December.

The cancer services contract is one half of a wider procurement process, worth £1.2 billion in total, being carried out by the four local clinical commissioning groups (CCGs). An end-of-life contract, with a value of £535 million, is also being tendered out.

Cannock Chase CCG, North Staffordshire CCG, Stafford & Surrounds CCG and Stoke-on-Trent CCG are the four CCGs tendering out the two contracts.

NHS Strategic Projects Team is running the process.


Related articles:

Posted on: 04/06/2015

Latest news stories

22/03/2019
A report by the National Audit Office has raised concerns over the lack of capacity in the NHS and resulting increase in waiting times for patients.
22/03/2019
Civitas Social Housing has acquired properties worth £85.6 million.
22/03/2019
VPS Healthcare, an Abu Dhabi-based hospital operator, is reconsidering plans to list on London Stock Exchange due to uncertainty surrounding Britain’s EU exit.
21/03/2019
The UK’s largest private healthcare provider is closing two of its hospitals and selling a third to the NHS.
21/03/2019
Healthcare software provider EMIS Group has reported growth in turnover and operating profit in its final results for the year ended 31 December 2018.


Civica


HealthInvestor blog
The chaos around the UK leaving the EU continues apace but healthcare investment is steering a steady course through the storm

Click here to view the HealthInvestor blog


A manufacturing aficionado intrigued by the possibilities tech offers to revolutionise health delivery and positively impact lives
abc ivf is offering IVF treatment at prices well below the industry average, suggesting it may have developed a winning formula – but are they cutting corners or is everyone else missing a trick, and what could it mean for the IVF sector and patients in future? Jeremy Bowden investigates
Where are the opportunities in care homes and retirement living? Carterwood’s director Tom Hartley and principal analyst Aishling Barrett analyse the sector’s supply and demand
Private equity interest in medical devices is growing. Catherine Gooderham takes a look at this complex and diverse market
The UK independent hospital sector has suffered considerable reputational damage in recent years. With falling NHS referrals and criticism from both the regulator and the government, Rob Munro looks at what changes are afoot to deal with a crisis of confidence in a market worth over £5 billion

Click here to search all feature articles



The private hospital sector

The UK independent hospital sector has suffered considerable reputational damage in recent years. With falling NHS referrals and criticism from both the regulator and the government, Rob Munro looks at what changes are afoot to deal with a crisis of confidence in a market worth over £5 billion
Read more


Christie + Co

my images



Company profile: Montreux Capital Management

The healthcare sector continues to evolve and it's the innovators that will shape its future. Marie Cahalane caught up with Oliver Harris, founder and chief executive of Montreux Capital Management, and quizzed him about his company's active approach to investment
Read more